HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

From quartz hazard to quartz risk: the coal mines revisited.

Abstract
Following the classification of quartz as a human carcinogen by the IARC, many standard-setting committees are currently trying to convert this hazard into their national or EU standards. Since human data to set a safe exposure limit for quartz are limited, we hypothesized that lung burden data on quartz in coal miners' lungs after lifetime exposure could be used to set a non-carcinogenic lung burden of quartz, and that this might be valid for other groups occupationally exposed to quartz. A review of data shows that lungs of coal miners with simple coal workers' pneumoconiosis (sCWP) typically contain up to 30 g of dust, and in one specific study lung burdens between 0.7 and 1.7 g of quartz were associated with macules only, and no sCWP. Assuming independent actions of coal and quartz and no clearance of quartz, and sCWP as a prerequisite for lung cancer due to quartz exposure in coal mine dust, a simple kinetic approach was applied. A no observed adverse effect level (NOAEL) for quartz of between 0.03 and 0.13 mg/m3 (40 yr exposure) is derived, but it is concluded that more refined physiologically based pharmacokinetic modelling is needed for a better estimate, also including interindividual differences in lung clearance. Considering the independent effects of, and the well-known interaction between coal and quartz, these data could be important to other workplaces with usual mixed-dust exposure.
AuthorsPaul J A Borm, Lang Tran
JournalThe Annals of occupational hygiene (Ann Occup Hyg) Vol. 46 Issue 1 Pg. 25-32 (Jan 2002) ISSN: 0003-4878 [Print] England
PMID12005128 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Dust
  • Quartz
Topics
  • Animals
  • Coal Mining
  • Dust
  • Humans
  • Lung Neoplasms (prevention & control)
  • No-Observed-Adverse-Effect Level
  • Occupational Exposure (adverse effects, standards)
  • Pneumoconiosis (epidemiology, etiology, prevention & control)
  • Quartz (toxicity)
  • Risk Assessment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: